[Severe perioperative thrombocytosis in a patient undergoing lung resection].
Severe thrombocytosis (platelet count > 1,000,000 microL(-1)) is a rare, usually reactive, process and few perioperative cases have been reported. We describe the management of a patient who developed severe reactive thrombocytosis in the preoperative period before undergoing segmentectomy to remove a malignant nodule. A platelet count of 2,086,000 microL(-1) was observed during the first few days after surgery; we therefore started antiplatelet therapy to prevent thrombotic complications. We analyze the factors that might have contributed to the development of severe thrombocytosis in this case and discuss the different treatment options that may affect perioperative outcomes in these patients.
Fernández Torres
B
B
Departamento de Anestesiología y Reanimación, Hospital Virgen Macarena, Sevilla. barfertor@tiscali.es
Ramos Martínez
E
E
Rosendo Ríos
R
R
Rodríguez Mejías
R
R
Gutiérrez Guillén
A
A
de las Mulas Béjar
M
M
D058186:Acute Kidney Injury / Q000150:complications; D000230:Adenocarcinoma; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D016470:Bacteremia / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D015897:Comorbidity; D016972:Enterobacter cloacae / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy; D017809:Fatal Outcome; D006801:Humans; D007964:Leukocytosis / Q000209:etiology; D008175:Lung Neoplasms / Q000097:blood / Q000601:surgery; D008297:Male; D016609:Neoplasms, Second Primary; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011013:Pneumonectomy / Q000009:adverse effects; D011183:Postoperative Complications / Q000097:blood / Q000209:etiology*; D011471:Prostatic Neoplasms; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood / Q000209:etiology; D020775:Thoracic Surgery, Video-Assisted / Q000009:adverse effects; D013908:Thoracotomy / Q000009:adverse effects; D013922:Thrombocytosis / Q000209:etiology*
D000900:Anti-Bacterial Agents; D010975:Platelet Aggregation Inhibitors